[{"id":511084,"catid":3,"update_time":1779325572,"title":"急性胰腺炎治疗纳米药物研究获突破","img":"","description":"本报讯（特约记者严丽通讯员周承汇王丹）中南大学湘雅医院龚学军教授团队在急性胰腺炎的纳米药物治疗领域取得突破。相关研究不仅深入探讨了急性胰腺炎的病理机制，还成功设计并验证了多种新型纳米药物，显著提升了急性胰腺炎的治疗效果，为临床治疗提供了全新视角和策略。相关研究论文日前分别发表于国...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0521\/511084.html"},{"id":511030,"catid":3,"update_time":1779237065,"title":"微\/纳米塑料在人脑中分布特征获揭示","img":"","description":"本报讯（记者吴倩特约记者卢国强）首都医科大学附属北京天坛医院、中国医学科学院北京协和医院、中国环境科学研究院开展的一项研究证实，人类活体大脑中存在微塑料（粒径小于5毫米的塑料颗粒）\/纳米塑料（粒径小于1微米的塑料颗粒），并系统揭示微\/纳米塑料在脑肿瘤组织及健康脑组织中的分布特征，...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0520\/511030.html"},{"id":510822,"catid":3,"update_time":1778548225,"title":"免疫性血小板减少症免疫干预或有新策略","img":"","description":"本报讯（特约记者聂文闻通讯员彭锦弦）华中科技大学同济医学院附属协和医院胡豫教授团队的一项研究，揭示了免疫性血小板减少症患者停药后无法维持的关键特征及其作用机制。该研究提出“有限疗程、长期缓解”的免疫干预新策略，为打破免疫性血小板减少症患者对血小板生成素（TPO）受体激动剂的长期依...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0512\/510822.html"},{"id":510716,"catid":3,"update_time":1778112243,"title":"新技术有望助力1型糖尿病干细胞治疗","img":"","description":"据新华社赫尔辛基电（记者朱昊晨徐谦）瑞典卡罗琳医学院日前发布公报说，该校研究人员参与的团队开发出一种新技术，可利用人类干细胞更稳定地制备胰岛素分泌细胞，有望推进1型糖尿病的干细胞治疗。相关研究论文已发表在学术期刊《干细胞报告》上。据公报介绍，1型糖尿病是一种自身免疫性疾病，患者体...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0507\/510716.html"},{"id":510715,"catid":3,"update_time":1778112212,"title":"基因编辑或让β-地贫患者摆脱输血","img":"","description":"本报讯（特约记者蓝飞燕通讯员何阳）广西医科大学第一附属医院地中海贫血防治研究团队联合上海科技大学、复旦大学等机构，利用变形式碱基编辑器（tBE）开发的碱基编辑药物CS-101注射液治疗β-地中海贫血，让接受治疗的5名患者均在短期内摆脱输血，重获健康造血能力。相关研究论文日前发表在...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0507\/510715.html"},{"id":510714,"catid":3,"update_time":1778112184,"title":"可凭眼底照预测不良心脑血管事件","img":"","description":"本报讯（记者崔芳）首都医科大学附属北京安贞医院冠心病中心曾勇教授团队开展的一项研究，验证了团队前期构建的一款基于视网膜眼底图像的多模态深度学习模型，可凭借一张眼底照实现无创、便捷地预测急性冠脉综合征（ACS）患者未来发生远期不良心脑血管事件的风险，证实了“眼脑心同源”在深度学习视...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0507\/510714.html"},{"id":510640,"catid":3,"update_time":1777512250,"title":"一种无创检测方法可预测胚胎着床潜能","img":"","description":"本报讯（记者崔芳）哈尔滨工业大学（深圳）陈华英教授和朱永刚教授团队联合深圳中山妇产医院陈培林副研究员团队，开发了一种基于微流控芯片的胚胎代谢物无创检测方法，为预测胚胎着床潜能提供了独立于形态学评估的新维度。近日，相关研究论文在《自然·通讯》上发表。在辅助生殖领域，一个长期悬而未决...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0430\/510640.html"},{"id":510563,"catid":3,"update_time":1777336856,"title":"过敏性气道炎症治疗有新策略","img":"","description":"本报讯（通讯员李俊达特约记者段文利）北京协和医院变态（过敏）反应科主任关凯、尹佳主任医师团队基于mRNA（信使核糖核酸）疫苗技术，构建了编码尘螨主要变应原Derp1和Derp2的脂质纳米颗粒递送体系，提出了一种新型变应原特异性免疫治疗策略，可用于干预尘螨诱导的过敏性气道炎症。相关...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0428\/510563.html"},{"id":510559,"catid":3,"update_time":1777336661,"title":"基因分析有助预测乳腺癌术前化疗效果","img":"","description":"据新华社斯德哥尔摩4月26日电（记者朱昊晨徐谦）瑞典卡罗琳医学院参与的一项新研究显示，通过分析乳腺癌肿瘤的基因表达特征，有望提前识别出哪些患者难以从术前化疗中获益，从而避免无效治疗，为乳腺癌个体化治疗提供依据。卡罗琳医学院日前发布新闻公报说，研究纳入179名雌激素受体阳性、人表皮...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0428\/510559.html"},{"id":510466,"catid":3,"update_time":1776907054,"title":"镇痛小分子新药取得关键突破","img":"","description":"本报讯（通讯员伍闻博查蒙特约记者郑纯胜）浙江大学医学院李晓明教授团队联合药学院董晓武教授和医学院张岩教授团队，通过“十年磨一剑”的研究，在过去成功解析大麻疗效机制和破解大麻“致毒密码”的基础上，原创设计出具有显著镇痛作用，且能削弱耐受、成瘾等副作用的新型小分子药物，为非阿片类镇痛...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0423\/510466.html"},{"id":510465,"catid":3,"update_time":1776907019,"title":"我国长效减重药研发跻身世界前列","img":"","description":"本报讯（记者崔芳特约记者钟艳宇）北京大学人民医院内分泌科纪立农教授团队牵头开展的我国原创1类新药博凡格鲁肽Ⅱ期临床研究显示，受试者在接受这款双周一次给药的胰高血糖素样肽-1受体激动剂（GLP-1RA）治疗30周后，减重效果显著，安全性和耐受性良好，且心血管代谢风险谱改善。这标志着...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0423\/510465.html"},{"id":510388,"catid":3,"update_time":1776733122,"title":"玫瑰痤疮持续性红斑治疗有了新策略","img":"","description":"本报讯（特约记者严丽通讯员肖文沁）近日，我国学者开展的一项研究取得突破，首次揭示了靶向代谢通路干预玫瑰痤疮血管功能障碍的分子机制，并以酮戊二酸受体1（OXGR1）为新靶点开发出新型激动剂，为解决玫瑰痤疮持续性红斑这一临床难题提供了全新治疗策略。该研究由中南大学湘雅医院李吉教授、邓...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0421\/510388.html"},{"id":510291,"catid":3,"update_time":1776299582,"title":"肿瘤免疫治疗有望进入“口服时代”","img":"","description":"本报讯（特约记者孙国根）复旦大学生命科学学院鲁伯埙教授团队与粤港澳大湾区精准医学研究院宋海坤团队，联合海军军医大学盛春泉团队，开创性地利用小分子化合物实现了对跨膜致病蛋白的高效、选择性降解，为肿瘤免疫治疗进入“口服时代”带来可能。相关研究论文近日在国际学术期刊《细胞》在线发表。如...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0416\/510291.html"},{"id":510285,"catid":3,"update_time":1776299340,"title":"光热微针或提供微创麻醉新方案","img":"","description":"本报讯（通讯员王帅磊干玎竹特约记者段文利）北京协和医院麻醉学系主任黄宇光团队联合北京化工大学郭新东教授团队，创新研发“近红外光激活盐酸利多卡因微针贴片给药系统”。该系统实现5分钟快速起效、持续作用60分钟的局部麻醉，具有无需注射、安全、快速等优势，有望为微创诊疗提供全新麻醉方案。...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0416\/510285.html"},{"id":510199,"catid":3,"update_time":1776125151,"title":"新指标能更好预测IgG4相关性疾病预后","img":"","description":"本报讯（通讯员彭琳一特约记者段文利）北京协和医院风湿免疫科张文主任医师、彭琳一副主任医师团队开展的一项研究，揭示了IgG4相关性疾病（IgG4-RD）患者治疗后血清总IgG的动态变化规律及其与预后的关联。近日，相关研究论文在风湿病学领域期刊《关节炎与风湿病学》上发表。IgG4-R...","thumb":"","extend_content":"","toptitle_color":"","title_color":"","subtitle_color":"","url":"2026\/0414\/510199.html"}]